Mitchell Chan

Companies

• REGENXBIO Inc.Chief financial officer Sep 18, 2024 to now¹
• Avalo Therapeutics, Inc.Board member Dec 3, 2021 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RREGENXBIO Inc. RGNX122,815 shares³$880.0K at $7.17Sep 1, 2026
• ATAvalo Therapeutics, Inc. AVTX3,166 shares⁴$35.7K at $11.27May 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Shares withheld for tax 4,902 shares at $9.32 of REGENXBIO Inc.³
• May 6, 2026Sold 3,167 shares at $22.88 of Avalo Therapeutics, Inc.⁴
• Mar 28, 2026Exercised options 3,166 shares of Avalo Therapeutics, Inc.⁵
• Jan 6, 2026Granted 73,749 shares of REGENXBIO Inc.⁶
• Sep 1, 2025Shares withheld for tax 4,901 shares at $8.93 of REGENXBIO Inc.⁷
• Mar 28, 2025Exercised options 3,167 shares of Avalo Therapeutics, Inc.⁸
• Sep 16, 2024Granted 58,869 shares of REGENXBIO Inc.⁹